Improving methods to analyze blood tests for COVID-19 and other diseases
Casual, Statistical and Mathematical Modeling with Serologic Data
This study is working on improving blood tests that check for COVID-19 antibodies to make sure the results are accurate and truly reflect the population, helping us understand how the virus spreads and how many people have immunity, which could also help with other diseases in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10852367 on NIH RePORTER |
What this research studies
This research focuses on enhancing the design and analysis of blood tests that measure antibodies in populations, particularly in relation to COVID-19. It aims to develop innovative statistical methods to ensure that the data collected from these tests is accurate and representative, addressing issues like biased sampling and the reliability of test results. By using serologic data, the research will create mathematical models to predict trends in disease spread and immunity, which could also be applied to other infectious diseases in the future.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been tested for COVID-19 or other infectious diseases and those interested in understanding their immune response.
Not a fit: Patients who are not interested in participating in serologic testing or those who have not been exposed to the diseases being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate assessments of immunity and disease prevalence, ultimately improving public health responses to infectious diseases.
How similar studies have performed: Previous research has shown success in using statistical modeling to analyze serologic data, making this approach both relevant and promising.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Lipsitch, Marc — Harvard School of Public Health
- Study coordinator: Lipsitch, Marc
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.